Gene · 623
Papers2,473
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,473
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Histamine H2 receptor antagonist exhibited comparable all-cause mortality-decreasing effect as β-blockers in critically ill patients with heart failure: a cohort study. | Front Pharmacol | 2023 | 38035020 | PubTator, text mining | PubMed |
The Effects of Remifentanil, Dexmedetomidine, and Metoral as Adjuncts to Thiopental on Hemodynamic Status After Electroconvulsive Therapy in Patients with Major Depressive Disorder: A Randomized Controlled Clinical Trial. | Anesth Pain Med | 2023 | 38028112 | PubTator, text mining | PubMed |
| Dimerization of melanocortin 4 receptor controls puberty onset and body size polymorphism. | Front Endocrinol (Lausanne) | 2023 | 38027153 | PubTator, text mining | PubMed |
| Mapping the Landscape of Health Research Priorities for Effective Pandemic Preparedness in Human Mpox Virus Disease. | Pathogens | 2023 | 38003816 | PubTator, text mining | PubMed |
| Empowering Renal Cancer Management with AI and Digital Pathology: Pathology, Diagnostics and Prognosis. | Biomedicines | 2023 | 38001875 | PubTator, text mining | PubMed |
| Influence of Different Types of β-Blockers on Mortality in Patients on Hemodialysis. | Biomedicines | 2023 | 37893212 | PubTator, text mining | PubMed |
| The Importance of Optimal Hydration in Patients with Heart Failure-Not Always Too Much Fluid. | Biomedicines | 2023 | 37893057 | PubTator, text mining | PubMed |
| Sepsis Management in the Cardiac Intensive Care Unit. | J Cardiovasc Dev Dis | 2023 | 37887876 | PubTator, text mining | PubMed |
| Prevention of Inflammation, Neovascularization, and Retinal Dysfunction by Kinin B1 Receptor Antagonism in a Mouse Model of Age-Related Macular Degeneration. | J Clin Med | 2023 | 37834856 | PubTator, text mining | PubMed |
| Bradykinin-bradykinin receptor (B1R) signalling is involved in the blood-brain barrier disruption in moyamoya disease. | J Cell Mol Med | 2023 | 37818853 | PubTator, text mining | PubMed |
| Strongly solved Ostle: calculating a strong solution helps compose high-quality puzzles for recent games. | PeerJ Comput Sci | 2023 | 37810330 | PubTator, text mining | PubMed |
| Remimazolam relieved the injury of hypoxia/reperfusion treated human embryo liver cell line through the targeting METTL3 mediated m6A modification of P53. | Heliyon | 2023 | 37809663 | PubTator, text mining | PubMed |
| Superiority of the Triple-Acting 5-HT6R/5-HT3R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT6R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats. | J Med Chem | 2023 | 37797083 | PubTator, text mining | PubMed |
| Modulation of Structure and Dynamics of Cardiac Troponin by Phosphorylation and Mutations Revealed by Molecular Dynamics Simulations. | J Phys Chem B | 2023 | 37791815 | PubTator, text mining | PubMed |
| The influence of metoprolol in patients with sepsis-induced cardiomyopathy: A retrospective study. | Saudi Med J | 2023 | 37777259 | PubTator, text mining | PubMed |
| Current Approaches in the Multimodal Management of Asthma in Adolescents-From Pharmacology to Personalized Therapy. | Biomedicines | 2023 | 37760870 | PubTator, text mining | PubMed |
| Endothelial Sp1/Sp3 are essential to the effect of captopril on blood pressure in male mice. | Nat Commun | 2023 | 37735515 | PubTator, text mining | PubMed |
| Pharmacotherapy in patients with vasomotor disorders. | Int J Cardiol Heart Vasc | 2023 | 37727753 | PubTator, text mining | PubMed |
| Sustained beneficial effect of β-blockers on clinical outcomes after discontinuation in patients with ST elevation myocardial infarction. | Medicine (Baltimore) | 2023 | 37713877 | PubTator, text mining | PubMed |
| Comparative HPTLC study for simultaneous determination of ivabradine and metoprolol using UV and fluorescence detectors. | BMC Chem | 2023 | 37710300 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/623/papers?page=6